Enfanos Analysis: $900K Raised
What is Enfanos?
Enfanos provides custom and targeted multiplex methods for enzyme activity and biomarker/metabolite assays. Founded by scientists from the University of Washington's Gelb lab, the company specializes in rare disease screening and inborn errors of metabolism. Their methodologies are designed to support newborn screening and clinical diagnostics globally.
Location
Seattle, United States
Employees
1-10
Founded
2018
Funding Status
Series A
Product Features & Capabilities
- Custom enzyme assay methods
- Targeted multiplex biomarker assays
- Quality Control DBS for biomarkers
- Enzyme assay kits
- Sample analysis services
Use Cases
Develop newborn screening protocols for lysosomal storage disorders; Validate biomarker assays for inborn errors of metabolism; Support clinical diagnostics for rare genetic conditions; Design multiplex assays for metabolic disease screening; Provide quality control standards for biomarker testing
Other Considerations
Founded by scientists from University of Washington's Gelb lab; Specializes in lysosomal storage disorders and newborn screening; Offers custom and targeted multiplex methods for enzyme and biomarker assays; Provides quality control DBS for biomarker testing
See something that needs updating? Suggest edits to this profile.